Watch | Coronavirus Updates, April 18: ICMR To Study Effectiveness of TB Vaccine Against COVID-19
Researchers in Boston, Australia and the Netherlands have also been conducting trials to investigate the potential of BCG against the novel coronavirus.
Pawanjot Kaur
Apr 19 2020
Advertisement
Real journalism holds power accountable
Since 2015, The Wire has done just that.
But we can continue only with your support.
ICMR will conduct a study to find the efficacy of the BCG vaccine against COVID-19. ICMR said that till any definitive result is reached it will not recommend the vaccine even for healthcare workers.
BCG is a vaccine primarily used against tuberculosis. Researchers in Boston, Australia and the Netherlands have also been conducting trials to investigate the potential of BCG against the novel coronavirus.
Advertisement
Advertisement
The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.
Advertisement
Make a contribution to Independent Journalism
Advertisement
